Is it too Late to Invest in Synergy Pharmaceuticals? (SGYP) | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 12 April, 2016 by The TZ Newswire Staff

Is it too Late to Invest in Synergy Pharmaceuticals? (SGYP)

Discover an upstart biotechnology stock trading near its 52-week low with a promising pipeline drug that may gain FDA approval by late 2016.

See also
- Next Article 7 stocks that almost always rise on earnings
- Previous Article UK March PPI input mm NSA + 2.0% vs +2.3% expected
Editorial Calender

April 2016

M T W T F S S

1 2 3

4 5 6 7 8 9 10

11 12 13 14 15 16 17

18 19 20 21 22 23 24

25 26 27 28 29 30

« Mar May »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar